Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Stopped This study was closed due to extremely low accrual, as well as a change in care when using the study drug.

Conditions

• Renal Cell Carcinoma
• Metastatic Kidney Cancer

Interventions

• DRUG: Pembrolizumab Injection [Keytruda]
• PROCEDURE: Cryoablation
• PROCEDURE: Nephrectomy

Sponsor

University of California, Irvine